Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice-Reference-Cited by-同舟云学术

Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice

Published:2022-02-23 Issue:4 Volume:48 Page:
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathology Appl Neurobio

Author:

Wilhelmus Micha M. M.¹,Chouchane Osoul¹,Loos Maarten²,Jongenelen Cornelis A. M.¹,Brevé John J. P.¹,Jonker Allert¹,Bol John G. J. M.¹,Smit August B.³,Drukarch Benjamin¹

Affiliation:

1. Department of Anatomy and Neurosciences, Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

2. Sylics (Synaptologics BV) Amsterdam The Netherlands

3. Department of Molecular and Cellular Neurobiology VU University Amsterdam Amsterdam The Netherlands

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nan.12796

Reference53 articles.

1. Amyloid β-Protein Fibrillogenesis

2. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-02-17

2. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease;Physiological Reviews;2024-01-01

3. Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective;Science China Life Sciences;2023-07-17

4. TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer’s disease;Biomedicine & Pharmacotherapy;2023-06